Research Article
Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis
Figure 4
ROC curve analysis of MMP-12 and MRGPRX2 as promising biomarkers for predicting the efficacy 1 year post-SLIT in AR patients. ROC: receiver operating characteristic; MMP-12: matrix metalloproteinase-12; MRGPRX2: mas-related G protein-coupled receptor-X2; SLIT: sublingual immunotherapy; AR: allergic rhinitis.